Stage Iiib Cutaneous Melanoma Ajcc V7

Top drugs studied for this disease

CLINICAL_TRIALS trial_result · 2021-05-27
Clinical Trial Update: Ipilimumab or High-Dose Interferon Alfa-2b in Treating Patients With High-Risk Stage III-IV Melanoma That Has Been Removed by Surgery [Phase 3]
This is a Phase 3 clinical trial update comparing ipilimumab to high-dose interferon alfa-2b in patients with resected high-risk Stage III–I…